Influence of time to endovascular stroke treatment on outcomes in the early versus extended window paradigms.


Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
Mar 2022
Historique:
pubmed: 17 3 2021
medline: 23 3 2022
entrez: 16 3 2021
Statut: ppublish

Résumé

The effect of time from stroke onset to thrombectomy in the extended time window remains poorly characterized. We aimed to analyze the relationship between time to treatment and clinical outcomes in the early versus extended time windows. Proximal anterior circulation occlusion patients from a multicentric prospective registry were categorized into early (≤6 h) or extended (>6-24 h) treatment window. Patients with baseline National Institutes of Health Stroke Scale (NIHSS) ≥ 10 and intracranial internal carotid artery or middle cerebral artery-M1-segment occlusion and pre-morbid modified Rankin scale (mRS) 0-1 ("DAWN-like" cohort) served as the population for the primary analysis. The relationship between time to treatment and 90-day mRS, analyzed in ordinal (mRS shift) and dichotomized (good outcome, mRS 0-2) fashion, was compared within and across the extended and early windows. A total of 1603 out of 2008 patients qualified. Despite longer time to treatment (9[7-13.9] vs. 3.4[2.5-4.3] h, The impact of time to thrombectomy on outcomes appears to be time dependent with a steep influence in the early followed by a less significant plateau in the extended window. However, every effort should be made to shorten treatment times regardless of ischemia duration.

Sections du résumé

BACKGROUND BACKGROUND
The effect of time from stroke onset to thrombectomy in the extended time window remains poorly characterized.
AIM OBJECTIVE
We aimed to analyze the relationship between time to treatment and clinical outcomes in the early versus extended time windows.
METHODS METHODS
Proximal anterior circulation occlusion patients from a multicentric prospective registry were categorized into early (≤6 h) or extended (>6-24 h) treatment window. Patients with baseline National Institutes of Health Stroke Scale (NIHSS) ≥ 10 and intracranial internal carotid artery or middle cerebral artery-M1-segment occlusion and pre-morbid modified Rankin scale (mRS) 0-1 ("DAWN-like" cohort) served as the population for the primary analysis. The relationship between time to treatment and 90-day mRS, analyzed in ordinal (mRS shift) and dichotomized (good outcome, mRS 0-2) fashion, was compared within and across the extended and early windows.
RESULTS RESULTS
A total of 1603 out of 2008 patients qualified. Despite longer time to treatment (9[7-13.9] vs. 3.4[2.5-4.3] h,
CONCLUSIONS CONCLUSIONS
The impact of time to thrombectomy on outcomes appears to be time dependent with a steep influence in the early followed by a less significant plateau in the extended window. However, every effort should be made to shorten treatment times regardless of ischemia duration.

Identifiants

pubmed: 33724080
doi: 10.1177/17474930211006304
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

331-340

Auteurs

Raul G Nogueira (RG)

Department of Neurology, 12239Emory University School of Medicine, Marcus Stroke & Neuroscience Center, 71741Grady Memorial Hospital, Atlanta, GA, USA.

Tudor G Jovin (TG)

Department of Neurology, 2202Cooper University Hospital Neurological Institute, Camden, NJ, USA.

Diogo C Haussen (DC)

Department of Neurology, 12239Emory University School of Medicine, Marcus Stroke & Neuroscience Center, 71741Grady Memorial Hospital, Atlanta, GA, USA.

Rishi Gupta (R)

Department of Neurosciences, Wellstar Health System, Atlanta, GA, USA.

Ashutov Jadhav (A)

Stroke Institute, Department of Neurology, 6614University of Pittsburgh Medical Center, PA, USA.

Ronald F Budzik (RF)

Department of Interventional Neuroradiology, 24601Riverside Methodist Hospital/Ohio Health Research Institute, Columbus, OH, USA.

Blaise Baxter (B)

Department of Radiology, Erlanger Hospital, Chattanooga, TN, USA.

Antonin Krajina (A)

Department of Radiology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.

Alain Bonafe (A)

Department of Neuroradiology, 26905CHU Montpellier, Montpellier, France.

Ali Malek (A)

St. Mary's Medical Center, West Palm Beach, FL, USA.

Ana Paula Narata (AP)

Department of Neuroradiology, CHU Tours, Tours, France.

Ryan Shields (R)

347070Stryker Neurovascular, Fremont, CA, USA.

Yanchang Zhang (Y)

347070Stryker Neurovascular, Fremont, CA, USA.

Patricia Morgan (P)

347070Stryker Neurovascular, Fremont, CA, USA.

Bruno Bartolini (B)

Department of Interventional Radiology, La Pitie Salpetriere, Paris, France.

Joey English (J)

3Department of Neurology, 7153California Pacific Medical Center, San Francisco, CA, USA.

Mahmoud Mohammaden (M)

Department of Neurology, 12239Emory University School of Medicine, Marcus Stroke & Neuroscience Center, 71741Grady Memorial Hospital, Atlanta, GA, USA.

Michael R Frankel (MR)

Department of Neurology, 12239Emory University School of Medicine, Marcus Stroke & Neuroscience Center, 71741Grady Memorial Hospital, Atlanta, GA, USA.

David S Liebeskind (DS)

Department of Neurology, UCLA, Los Angeles, CA, USA.

Erol Veznedaroglu (E)

Department of Neurosciences, Drexel Neurosciences Institute, Philadelphia, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH